IMCR
Immunocore Holdings plc
+0.70 (+2.22%)32.29USD66.9K成交股數–市值–本益比(近四季)–股價營收比+18.3%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | 02-19 | Jallal Bahija | CHIEF EXECUTIVE OFFICER | S 公開市場賣出 | 11.5K | 32.35 | 371K | 12.3K | SEC |
| 2026-02-18 | 02-19 | GOLL JOHN | SVP, FINANCE & CAO | S 公開市場賣出 | 698 | 32.35 | 23K | 653 | SEC |
| 2026-02-18 | 02-19 | Berman David M | HEAD OF R&D | S 公開市場賣出 | 6.0K | 32.35 | 193K | 5.9K | SEC |
| 2026-02-18 | 02-19 | St Leger Tina Amber | CHIEF HR OFFICER | S 公開市場賣出 | 1.0K | 32.35 | 32K | 1.1K | SEC |
| 2026-02-17 | 02-19 | Jallal Bahija | CHIEF EXECUTIVE OFFICER | M 選擇權執行 | 23.8K | – | – | 23.8K | SEC |
| 2026-02-17 | 02-19 | GOLL JOHN | SVP, FINANCE & CAO | M 選擇權執行 | 1.4K | – | – | 1.4K | SEC |
| 2026-02-17 | 02-19 | St Leger Tina Amber | CHIEF HR OFFICER | M 選擇權執行 | 2.1K | – | – | 2.1K | SEC |
| 2026-02-17 | 02-19 | Berman David M | HEAD OF R&D | M 選擇權執行 | 11.8K | – | – | 11.8K | SEC |
| 2025-12-05 | 12-08 | Berman David M | HEAD OF R&D | M 選擇權執行 | 572 | 17.46 | 10K | 572 | SEC |
| 2025-12-05 | 12-08 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 572 | 40.14 | 23K | 0 | SEC |
| 2025-12-04 | 12-08 | Berman David M | HEAD OF R&D | M 選擇權執行 | 31.3K | 17.46 | 547K | 31.3K | SEC |
| 2025-12-04 | 12-08 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 31.3K | 40.26 | 1.3M | 0 | SEC |
| 2025-11-28 | 12-01 | Berman David M | HEAD OF R&D | M 選擇權執行 | 5.5K | 17.46 | 96K | 5.5K | SEC |
| 2025-11-28 | 12-01 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 5.5K | 40.09 | 221K | 0 | SEC |
| 2025-11-26 | 12-01 | Berman David M | HEAD OF R&D | M 選擇權執行 | 69.4K | 17.46 | 1.2M | 69.4K | SEC |
| 2025-11-26 | 12-01 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 69.4K | 40.12 | 2.8M | 0 | SEC |
| 2025-11-25 | 11-26 | Berman David M | HEAD OF R&D | M 選擇權執行 | 18.0K | 17.46 | 315K | 18.0K | SEC |
| 2025-11-25 | 11-26 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 18.0K | 40.03 | 721K | 0 | SEC |
| 2025-11-24 | 11-26 | Berman David M | HEAD OF R&D | M 選擇權執行 | 100 | 17.46 | 2K | 100 | SEC |
| 2025-11-24 | 11-26 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 100 | 40.00 | 4K | 0 | SEC |
| 2025-09-30 | 10-02 | Berman David M | HEAD OF R&D | M 選擇權執行 | 61.8K | 17.46 | 1.1M | 61.8K | SEC |
| 2025-09-30 | 10-02 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 61.8K | 35.23 | 2.2M | 0 | SEC |
| 2025-09-15 | 09-16 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 200 | 35.01 | 7K | 0 | SEC |
| 2025-09-15 | 09-16 | Berman David M | HEAD OF R&D | M 選擇權執行 | 200 | 17.46 | 3K | 200 | SEC |
| 2025-09-12 | 09-16 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 1.3K | 36.31 | 47K | 0 | SEC |
| 2025-09-12 | 09-16 | Berman David M | HEAD OF R&D | M 選擇權執行 | 22.5K | 17.46 | 393K | 22.5K | SEC |
| 2025-09-12 | 09-16 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 21.2K | 35.63 | 756K | 1.3K | SEC |
| 2025-09-11 | 09-12 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 19.1K | 36.28 | 692K | 0 | SEC |
| 2025-09-11 | 09-12 | Berman David M | HEAD OF R&D | M 選擇權執行 | 19.1K | 17.46 | 333K | 19.1K | SEC |
| 2025-09-10 | 09-12 | Berman David M | HEAD OF R&D | M 選擇權執行 | 31.3K | 17.46 | 547K | 31.3K | SEC |
| 2025-09-10 | 09-12 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 30.1K | 36.12 | 1.1M | 1.2K | SEC |
| 2025-09-10 | 09-12 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 1.2K | 36.77 | 44K | 0 | SEC |
| 2025-03-17 | 03-19 | Baker Brothers Life Sciences LP | Director | P 公開市場買進 | 8.6K | 29.56 | 254K | 179K | SEC |
| 2025-03-17 | 03-19 | BAKER JULIAN | Director | P 公開市場買進 | 60.1K | 29.74 | 1.8M | 170K | SEC |
| 2025-03-17 | 03-19 | BAKER JULIAN | Director | P 公開市場買進 | 646K | 29.74 | 19.2M | 2.1M | SEC |
| 2025-03-17 | 03-19 | BAKER JULIAN | Director | P 公開市場買進 | 8.6K | 29.56 | 254K | 179K | SEC |
| 2025-03-17 | 03-19 | BAKER JULIAN | Director | P 公開市場買進 | 92.3K | 29.56 | 2.7M | 2.1M | SEC |
| 2025-03-17 | 03-19 | BAKER FELIX | Director | P 公開市場買進 | 60.1K | 29.74 | 1.8M | 170K | SEC |
| 2025-03-17 | 03-19 | BAKER FELIX | Director | P 公開市場買進 | 646K | 29.74 | 19.2M | 2.1M | SEC |
| 2025-03-17 | 03-19 | BAKER FELIX | Director | P 公開市場買進 | 8.6K | 29.56 | 254K | 179K | SEC |
| 2025-03-17 | 03-19 | BAKER FELIX | Director | P 公開市場買進 | 92.3K | 29.56 | 2.7M | 2.1M | SEC |
| 2025-03-17 | 03-19 | BAKER BROS. ADVISORS LP | Director | P 公開市場買進 | 60.1K | 29.74 | 1.8M | 170K | SEC |
| 2025-03-17 | 03-19 | BAKER BROS. ADVISORS LP | Director | P 公開市場買進 | 646K | 29.74 | 19.2M | 2.1M | SEC |
| 2025-03-17 | 03-19 | BAKER BROS. ADVISORS LP | Director | P 公開市場買進 | 8.6K | 29.56 | 254K | 179K | SEC |
| 2025-03-17 | 03-19 | BAKER BROS. ADVISORS LP | Director | P 公開市場買進 | 92.3K | 29.56 | 2.7M | 2.1M | SEC |
| 2025-03-17 | 03-19 | Baker Brothers Life Sciences LP | Director | P 公開市場買進 | 60.1K | 29.74 | 1.8M | 170K | SEC |
| 2025-03-17 | 03-19 | Baker Brothers Life Sciences LP | Director | P 公開市場買進 | 646K | 29.74 | 19.2M | 2.1M | SEC |
| 2025-03-17 | 03-19 | Baker Brothers Life Sciences LP | Director | P 公開市場買進 | 92.3K | 29.56 | 2.7M | 2.1M | SEC |
| 2025-03-17 | 03-19 | 667, L.P. | Director | P 公開市場買進 | 60.1K | 29.74 | 1.8M | 170K | SEC |
| 2025-03-17 | 03-19 | 667, L.P. | Director | P 公開市場買進 | 646K | 29.74 | 19.2M | 2.1M | SEC |
| 2025-03-17 | 03-19 | 667, L.P. | Director | P 公開市場買進 | 8.6K | 29.56 | 254K | 179K | SEC |
| 2025-03-17 | 03-19 | 667, L.P. | Director | P 公開市場買進 | 92.3K | 29.56 | 2.7M | 2.1M | SEC |
| 2025-03-17 | 03-19 | Baker Bros. Advisors (GP) LLC | Director | P 公開市場買進 | 60.1K | 29.74 | 1.8M | 170K | SEC |
| 2025-03-17 | 03-19 | Baker Bros. Advisors (GP) LLC | Director | P 公開市場買進 | 646K | 29.74 | 19.2M | 2.1M | SEC |
| 2025-03-17 | 03-19 | Baker Bros. Advisors (GP) LLC | Director | P 公開市場買進 | 8.6K | 29.56 | 254K | 179K | SEC |
| 2025-03-17 | 03-19 | Baker Bros. Advisors (GP) LLC | Director | P 公開市場買進 | 92.3K | 29.56 | 2.7M | 2.1M | SEC |
| 2024-04-01 | 04-03 | St Leger Tina Amber | CHIEF HR OFFICER | S 公開市場賣出(10b5-1) | 4.4K | 64.06 | 280K | 0 | SEC |
| 2024-04-01 | 04-03 | St Leger Tina Amber | CHIEF HR OFFICER | M 選擇權執行 | 4.4K | 29.87 | 131K | 4.4K | SEC |
| 2024-02-28 | 03-01 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 7.5K | 68.84 | 514K | 12.1K | SEC |
| 2024-02-28 | 03-01 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 10.9K | 69.73 | 763K | 1.2K | SEC |
| 2024-02-28 | 03-01 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 1.2K | 70.45 | 85K | 0 | SEC |
| 2024-02-28 | 03-01 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 16.9K | 67.61 | 1.1M | 19.6K | SEC |
| 2024-02-28 | 03-01 | Berman David M | HEAD OF R&D | M 選擇權執行 | 36.5K | 17.46 | 637K | 36.5K | SEC |
| 2024-02-27 | 02-28 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 4.4K | 69.45 | 309K | 50.5K | SEC |
| 2024-02-27 | 02-28 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 25.9K | 71.32 | 1.9M | 3.4K | SEC |
| 2024-02-27 | 02-28 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 3.4K | 71.97 | 244K | 0 | SEC |
| 2024-02-27 | 02-28 | Berman David M | HEAD OF R&D | M 選擇權執行 | 54.9K | 17.46 | 959K | 54.9K | SEC |
| 2024-02-27 | 02-28 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 21.2K | 70.42 | 1.5M | 29.3K | SEC |
| 2024-02-26 | 02-28 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 2.0K | 71.31 | 145K | 0 | SEC |
| 2024-02-26 | 02-28 | Berman David M | HEAD OF R&D | M 選擇權執行 | 28.6K | 17.46 | 499K | 28.6K | SEC |
| 2024-02-26 | 02-28 | Berman David M | HEAD OF R&D | S 公開市場賣出(10b5-1) | 26.5K | 70.60 | 1.9M | 2.0K | SEC |
| 2024-01-03 | 01-05 | St Leger Tina Amber | Chief HR Officer | M 選擇權執行 | 4.4K | 29.87 | 131K | 4.4K | SEC |
| 2024-01-03 | 01-05 | St Leger Tina Amber | Chief HR Officer | S 公開市場賣出(10b5-1) | 4.1K | 69.85 | 284K | 307 | SEC |
| 2024-01-03 | 01-05 | St Leger Tina Amber | Chief HR Officer | S 公開市場賣出(10b5-1) | 307 | 70.46 | 22K | 0 | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 5.7M | 182M | 新進 | 新進 |
| RTW INVESTMENTS, LP | 4.9M | 155M | 新進 | 新進 |
| FMR LLC | 4.3M | 137M | 新進 | 新進 |
| PRIMECAP MANAGEMENT CO/CA/ | 3.6M | 116M | 新進 | 新進 |
| Bellevue Group AG | 2.8M | 88.5M | 新進 | 新進 |
| TANG CAPITAL MANAGEMENT LLC | 2.6M | 84.1M | 新進 | 新進 |
| Vestal Point Capital, LP | 1.8M | 57.2M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 1.6M | 52.4M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 1.6M | 50.7M | 新進 | 新進 |
| ARMISTICE CAPITAL, LLC | 1.4M | 45.3M | 新進 | 新進 |
| Caligan Partners LP | 1.4M | 43.9M | 新進 | 新進 |
| Kynam Capital Management, LP | 1.4M | 43.7M | 新進 | 新進 |
| BVF INC/IL | 1.3M | 41.1M | 新進 | 新進 |
| Trails Edge Capital Partners, LP | 1.1M | 33.8M | 新進 | 新進 |
| BlackRock, Inc. | 1.0M | 31.9M | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 990K | 31.4M | 新進 | 新進 |
| Jupiter Topco LLC | 709K | 22.5M | 新進 | 新進 |
| CANTOR FITZGERALD, L. P. | 680K | 21.6M | 新進 | 新進 |
| Logos Global Management LP | 600K | 19.1M | 新進 | 新進 |
| MARSHALL WACE, LLP | 591K | 18.8M | 新進 | 新進 |
| Hudson Bay Capital Management LP | 590K | 18.7M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 567K | 18.0M | 新進 | 新進 |
| BRAIDWELL LP | 521K | 16.6M | 新進 | 新進 |
| Jones Hill Capital LP | 513K | 16.3M | 新進 | 新進 |
| PRINCIPAL FINANCIAL GROUP INC | 486K | 15.4M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 136 -6 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 136 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 52.4M |
| 合計季末市值 | 1.6B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 7.8M |
|---|---|
| 與上期比 | -1.3% |
| 佔流通股數 | –(外國發行人不算) |
| 日均成交量 | 375K |
| 回補天數 | 20.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 7.8M | -1.3% | – | 375K | 20.8 |
| 2026-08-14 | 7.9M | -3.9% | – | 420K | 18.8 |
| 2026-07-31 | 8.2M | -8.1% | – | 473K | 17.4 |
| 2026-07-15 | 8.9M | -0.6% | – | 708K | 12.6 |
| 2026-06-30 | 9.0M | -0.5% | – | 719K | 12.5 |
| 2026-06-15 | 9.0M | +3.3% | – | 423K | 21.4 |
| 2026-05-29 | 8.7M | -2.5% | – | 444K | 19.7 |
| 2026-05-15 | 9.0M | +0.0% | – | 253K | 35.4 |
| 2026-04-30 | 9.0M | -8.3% | – | 431K | 20.8 |
| 2026-04-15 | 9.8M | -3.6% | – | 433K | 22.6 |
| 2026-03-31 | 10.1M | +0.1% | – | 389K | 26.1 |
| 2026-03-13 | 10.1M | -15.4% | – | 356K | 28.5 |
| 2026-02-27 | 12.0M | +5.5% | – | 381K | 31.4 |
| 2026-02-13 | 11.4M | +3.9% | – | 387K | 29.4 |
| 2026-01-30 | 10.9M | +9.1% | – | 624K | 17.5 |
| 2026-01-15 | 10.0M | +5.2% | – | 393K | 25.5 |
| 2025-12-31 | 9.5M | +5.2% | – | 260K | 36.6 |
| 2025-12-15 | 9.1M | +5.7% | – | 290K | 31.2 |
| 2025-11-28 | 8.6M | -2.3% | – | 388K | 22.1 |
| 2025-11-14 | 8.8M | +1.3% | – | 259K | 33.9 |
| 2025-10-31 | 8.7M | -0.1% | – | 273K | 31.7 |
| 2025-10-15 | 8.7M | +3.6% | – | 361K | 24.0 |
| 2025-09-30 | 8.4M | -3.8% | – | 315K | 26.5 |
| 2025-09-15 | 8.7M | -0.4% | – | 293K | 29.7 |
| 2025-08-29 | 8.7M | -0.9% | – | 258K | 33.8 |
| 2025-08-15 | 8.8M | +5.7% | – | 348K | 25.4 |